Batch: GF-GLUTA600-B241 Assay Content: 580 mg Purity: greater than 99.8 percent Identification by FTIR Spectrum: 1000 Identification by Retention Time: 0.985 Molecular Ion Mass Identification: 307 Da Bacterial Endotoxins: below 0.001 EU/mg Total Aerobic Microbial Count: 0 CFU/g Total Yeast and Mold Count: 0 CFU/g Independent elemental impurity analysis confirmed no detectable arsenic, cadmium, cobalt, lead, mercury, nickel or vanadium, with all measured concentrations remaining below the laboratory detection limit
GHK-Cu is well-tolerated across skin types, including sensitive skin, due to its anti-inflammatory effects
Drug Pathway: No FDA New Drug Approval The FDA drug approval system is based on the NDA (New Drug Application) process
In models of retinal degeneration, Epitalon has been delivered via parabulbar injection, a technique that places the compound near the posterior eye to maximize local availability [64, 65]
10.1016/j.jot.2025.01.001 109 XuZ.ChenL.WangC.ZhangL.XuW
Specifications Product name: Epitalon Synonyms: Epithalon